# EDGAR Filing Document

**Accession Number:** 0001856995
**File Stem:** 0001104659-23-010167
**Filing Date:** 2023-2
**Character Count:** 8056
**Document Hash:** 9e90a733c5cfc7f3d709fb592767fb11
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-010167.hdr.sgml**: 20230203

**ACCESSION NUMBER**: 0001104659-23-010167

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20230203

**ITEM INFORMATION**: Regulation FD Disclosure

**FILED AS OF DATE**: 20230203

**DATE AS OF CHANGE**: 20230203

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Mountain & Co. I Acquisition Corp.
- **CENTRAL INDEX KEY:** 0001856995
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41021
- **FILM NUMBER:** 23583701

**BUSINESS ADDRESS:**
- **STREET 1:** PO BOX 309, UGLAND HOUSE
- **CITY:** GRAND CAYMAN
- **STATE:** E9
- **ZIP:** KY1-1104
- **BUSINESS PHONE:** 41 79 555 00 66

**MAIL ADDRESS:**
- **STREET 1:** PO BOX 309, UGLAND HOUSE
- **CITY:** GRAND CAYMAN
- **STATE:** E9
- **ZIP:** KY1-1104

?xml version="1.0" encoding="utf-8"?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

**FORM 8-K**

**CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported):

**February 3, 2023**

**MOUNTAIN & CO. I ACQUISITION CORP.**

(Exact Name of Registrant as Specified in its Charter)

---

| | | |
|:---|:---|:---|
| **Cayman Islands** | **001-41021** | **N/A** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (I.R.S. Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **4001 Kennett Pike, Suite 302**<br> **Wilmington, Delaware 19807** | **19807** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

---

| |
|:---|
| **+1 302 273 0765** |
| Registrant's telephone number, including area code: |

---

---

| |
|:---|
| **Not Applicable** |
| (Former name or former address, if changed since last report) |

---

---

| |
|:---|
| Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |
| ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ◻ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

---

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | &nbsp;&nbsp;**Trading <br> Symbol(s)** | **Name of each exchange<br> on which registered** |
| **Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant** | **MCAAU** | **The Nasdaq Stock Market LLC** |
| **Class A ordinary share, par value $0.0001 per share** | **MCAA** | **The Nasdaq Stock Market LLC** |
| **Redeemable warrant, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50** | **MCAAW** | **The Nasdaq Stock Market LLC** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;⌧ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

¨ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

---

| | |
|:---|:---|
| **Item 7.01** | **Regulation FD Disclosure.** |

---

**Preliminary Redemption Results**

Mountain & Co. I Acquisition Corp. (the "Company") encourages shareholders to vote in favor of the proposal to amend the Company's Amended and Restated Memorandum and Articles of Association (the "Articles Extension") to extend the date by which the Company must complete a business combination from February 9, 2023 to November 9, 2023 (the "Extension"). As disclosed in the Company's definitive proxy statement, filed with the SEC on January 19, 2023, a meeting of the Company's shareholders to approve the Articles Extension is scheduled to be held on February 6, 2023 at 10:00 a.m., Eastern Time. The Extension will provide the Company with additional time to complete its business combination.

As of 5:00 p.m., Eastern Time, on February 2, 2023, the redemption deadline, holders of 11,614,962 Class A ordinary shares had elected to have their shares redeemed, resulting in 11,385,038 Class A ordinary shares remaining outstanding after giving effect to such redemptions.

The Company announced today that shareholders may withdraw any election to have their Class A ordinary shares redeemed in connection with the Extension by 5:00 p.m., Eastern Time, on Friday, February 3, 2023. Shareholders who wish to withdraw redemptions should contact the Company's transfer agent, Continental Stock Transfer & Trust Company, by email at mzimkind@continentalstock.com.

**Forward Looking Statements**

This document includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. These forward-looking statements and factors that may cause such differences include, without limitation, uncertainties relating to our ability to obtain approval for the Articles Extension, our ability to complete our initial business combination, and other risks and uncertainties indicated from time to time in filings with the SEC, including "Risk Factors" in the Extension Proxy Statement (as defined below) and in other reports we file with the SEC. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

**Additional Information and Where to Find It**

THE COMPANY urges shareholders to read the definitive proxy statement filed with the SEC on JANUARY 19, 2023 (the "Extension Proxy Statement"), as well as other documents filed by THE COMPANY with the SEC, because these documents contain important information about THE COMPANY AND the Extension. Shareholders may obtain copies of these documents (when available), without charge, at the SEC's website at www.sec.gov or by directing a request to: Mountain & Co. I Acquisition Corp., 4001 Kennett Pike, Suite 302 Wilmington, Delaware 19807, Attn: Secretary.

**Participants in Solicitation**

The Company and its directors and executive officers may be deemed to be participants in the solicitation of proxies of the Company shareholders. Investors and security holders may obtain more detailed information regarding the names, affiliations and interests of the Company's directors and officers in the Extension Proxy Statement which may be obtained free of charge from the sources indicated above.

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  | MOUNTAIN & CO. I ACQUISITION CORP. | MOUNTAIN & CO. I ACQUISITION CORP. | MOUNTAIN & CO. I ACQUISITION CORP. |
| Date: February 3, 2023 | By: | /s/ Dr. Cornelius Boersch | /s/ Dr. Cornelius Boersch |
|  |  | Name: | Dr. Cornelius Boersch |
|  |  | Title: | Chief Executive Officer |

---